An interesting question also arises: whether variable antigen expression may also have implications on antibody localization and hence effectiveness of anti-HER2 therapy as after all accessibility and binding of injected antibody do depend on concentration as well as location of antigen on tumor cell membranes. The gene discussed is ERBB2; the disease is neoplasm.